Non-survivor septic patients have persistently higher serum sCD40L levels than survivors

Leonardo Lorente,María M. Martín,Antonia Pérez-Cejas,José Ferreres,Jordi Solé-Violán,Lorenzo Labarta,César Díaz,Alejandro Jiménez

Journal of Critical Care（2017）

Cited 9|Views9

No score

Abstract

•Serum sCD40L levels are persistently higher during the first week in non-survivor than in survivor patients.•There is an association between serum sCD40L levels during the first week and sepsis mortality.•Serum sCD40L levels during the first week could be used as sepsis mortality biomarker.

Translated text

Key words

sCD40L,Sepsis,Mortality

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined